VCANBIO
600645----
Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: VCANBIO(600645) the Revenue is 342.03 M (-6.44%);the EBIT is 40.51 M (+21.4%);the EPS is 0.081 (+14.84%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.34B6.44%
----
----
EBIT
0.04B21.40%
----
----
EPS
0.08114.84%
----
----
Upcoming earnings report - Q3 FY2026
Available dateOct 30, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: CNY
Quarterly
EBIT
ActualEstimateUnit: CNY
Quarterly
Net income
ActualEstimateUnit: CNY
Quarterly
EPS
ActualEstimateUnit: CNY
Quarterly